Get started
Author

Yiqi Su

ORCID: 0009-0008-7276-2772
Observed ORCIDs: 0009-0008-7276-2772, 0000-0003-1042-3878
OpenAlex ID: A5064763237
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience
2019 · Andrew Lin, Molly Maloy, et al. · Transplant Infectious Disease · 87
Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
2023 · Susan E. Prockop, Aisha Hasan, et al. · Journal of Clinical Investigation · 57
PDF
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
2020 · Anat Stern, Yiqi Su, et al. · Transplantation and Cellular Therapy · 57
Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study
2020 · Phaedon Zavras, Yiqi Su, et al. · Transplantation and Cellular Therapy · 56
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort Study
2022 · Yiqi Su, Anat Stern, et al. · Clinical Infectious Diseases · 47
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients
2021 · Yael Bogler, Anat Stern, et al. · Medical Mycology · 34
Cytomegalovirus Viral Load Kinetics Predict Cytomegalovirus End-Organ Disease and Mortality After Hematopoietic Cell Transplant
2021 · Anat Stern, Yiqi Su, et al. · The Journal of Infectious Diseases · 23
Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation
2020 · Jiaqi Fang, Yiqi Su, et al. · Transplantation and Cellular Therapy · 22
Inhibition of matrix metalloproteinase-9 attenuates kidney fibrosis and cellular senescence in the transition from acute kidney injury to chronic kidney disease
2025 · Daoqi Shen, Liyu Lin, et al. · Renal Failure · 15
PDF
Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell Transplantation
2024 · Carrie A. Tan, Lauren Palen, et al. · Transplantation and Cellular Therapy · 15
Outcomes of Refractory Cytomegalovirus Infection in the First Year after Allogeneic Hematopoietic Cell Transplantation
2022 · Eleni Karantoni, Phaedon D. Zavras, et al. · Transplantation and Cellular Therapy · 12
Cytomegalovirus Infection in Allogeneic Hematopoietic Cell Transplantation Managed by the Preemptive Approach: Estimating the Impact on Healthcare Resource Utilization and Outcomes
2018 · Yao-Ting Huang, Yiqi Su, et al. · Transplantation and Cellular Therapy · 11
Assessing the predictive value of elevated postoperative syndecan-1 levels for progressive acute kidney injury and kidney replacement therapy necessity in adult cardiac surgery patients
2024 · Wuhua Jiang, Ying Su, et al. · BMC Cardiovascular Disorders · 9
PDF
Human Herpesvirus 6 DNAemia Is Associated With Worse Survival After Ex Vivo T-Cell–Depleted Hematopoietic Cell Transplant
2021 · Yeon Joo Lee, Yiqi Su, et al. · The Journal of Infectious Diseases · 8
Syndecan-1 regulates lipid metabolism and mitigates fibrosis during the transition from acute kidney injury to chronic kidney disease
2025 · Daoqi Shen, Liyu Lin, et al. · Metabolism · 7
Enhancing Fairness and Accuracy in Diagnosing Type 2 Diabetes in Young Population
2023 · Tanmoy Sarkar Pias, Yiqi Su, et al. · medRxiv · 7
PDF
Early Efficacy and Safety of Finerenone on Type 2 Diabetes‐Related Chronic Kidney Disease: A Real‐World Observational Study in China
2025 · Liyu Lin, Ziyan Shen, et al. · Diabetes/Metabolism Research and Reviews · 6
PDF
Effects of hyperuricaemia, with the superposition of being overweight and hyperlipidaemia, on the incidence of acute kidney injury following cardiac surgery: a retrospective cohort study
2022 · Yiqi Su, Haoxuan Li, et al. · BMJ Open · 4
PDF
595. Letermovir (LTV) for Secondary Cytomegalovirus (CMV) Prevention in High Risk Hematopoietic Cell Transplant (HCT) Recipients: Interim Results of a Single Center, Open Label Study
2021 · Gyuri Han, Anat Stern, et al. · Open Forum Infectious Diseases · 4
Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic
2022 · Kayla R. Maki, Samantha N. Steiger, et al. · Infection Control and Hospital Epidemiology · 3
Association between perioperative platelet distribution width changes and postoperative acute kidney injury in patients with renal insufficiency: a retrospective study
2024 · Yiqi Su, Xialian Xu, et al. · BMC Nephrology · 2
PDF
Donor-CD4+ T Cells: A Trojan Horse for Human Herpes Virus-6 After Allogeneic Hematopoietic Cell Transplantation?
2021 · Yeon Joo Lee, Yiqi Su, et al. · The Journal of Infectious Diseases · 2
1104. Risk Factors and Outcomes of Refractory and/or Resistant Cytomegalovirus (CMV) Infection after Allogeneic Hematopoietic Stem Cell Transplantation
2020 · Eleni Karantoni, Yiqi Su, et al. · Open Forum Infectious Diseases · 1
1742. Kinetics of CMV Viremia with Letermovir Prophylaxis in the First 100 Days post Hematopoietic Cell Transplantation (HCT): A Single-center Experience
2019 · Phaedon D Zavras, Anat Stern, et al. · Open Forum Infectious Diseases · 1
PDF
Soluble suppression of tumorigenicity 2 and cardiovascular outcomes across serum uric acid strata in maintenance hemodialysis: an exploratory secondary analysis
2026 · Yiqi Su, Zhen Zhang, et al. · Clinica Chimica Acta
Works count: 34
Citation count: 489
H-index: 11
I10-index: 12
Year
Topic
Type